13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuropharmacology and Novel Drug Development
The field of neuropharmacology and novel drug development delves into the biochemical pathways and molecular targets underlying neurological function and dysfunction. This research area is pivotal in driving the creation of innovative drugs, ranging from neuroprotective agents to neuromodulators. Advanced methodologies, such as CRISPR-based genome editing and nanotechnology, are transforming the delivery and effectiveness of neurotherapeutics. Researchers are also focusing on strategies to overcome the challenges of the blood-brain barrier, ensuring enhanced drug delivery to the central nervous system. With a strong focus on addressing unmet clinical needs, neuropharmacology is expanding the frontiers of science, paving the way for groundbreaking solutions to neurological and psychiatric disorders.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Toru Kondo
Hokkaido University, Japan
Isao Okunishi
Kinjirushi Co., Ltd, Japan
Thomas J Webster
Brown University, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Spring break: A true story of hope and determination
Steven Benvenisti, Davis, Saperstein Salomon, PC, United States
Title : The role of compromised cerebrospinal fluid circulation in sleep apnea
Joe Sam Robinson, Mercer University, United States
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Nervous system effects in chemicals with immediately dangerous to life or health values
Sudha P Pandalai, National Institute for Occupational Safety and Health, United States
Title : Clinical outcomes of AI-augmented cognitive rehabilitation in dementia and mild cognitive impairment
Esra Al, NewDays, United States
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States